Gingivitis reduction is "basis for" plaque/gingivitis monograph, subcmte. chair says.
This article was originally published in The Tan Sheet
Executive Summary
GINGIVITIS REDUCTION "BASIS FOR" PLAQUE/GINGIVITIS MONOGRAPH INCLUSION "with or without plaque reduction," FDA Dental Products Panel Plaque Subcommittee Chairman Robert Genco, PhD/DDS, SUNY-Buffalo, said at the subcommittee's May 8-9 meeting in Bethesda, Md. Claims for plaque reduction and gingivitis reduction will "not necessarily" be "tied together" in the FDA monograph, he commented, adding that "for the monograph, we're emphasizing anti-gingivitis" claims.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning